Skip to search formSkip to main contentSkip to account menu

LY 215490

Known as: LY-215490 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tezampanel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
LY-293558. Eli Lilly & Co.
Lilly is developing the racemic compound LY-215490, a selective and competitive AMPA antagonist, as a potential treatment for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)